Angiotensin II for severe low blood pressure in children
Treatments studied
Part of Heart & circulation clinical trials.
This study tests an IV medicine called angiotensin II (Giapreza) to raise blood pressure in children who are very sick and not responding to standard treatments. It aims to see if this medicine can help stabilize blood pressure and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 18 years old.
- Your child must have dangerously low blood pressure that isn't helped by standard fluids or blood pressure medicines.
- Your child must have special tubes (arterial and central lines) placed to monitor blood pressure and give medicines.
- You must be willing and able to give permission and help your child follow the study rules.
- There are other medical situations that would make a child not eligible, such as certain heart problems, active bleeding, or other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an injection of angiotensin II (a substance that helps tighten blood vessels) versus a placebo for patients with distributive shock that is not responding to standard treatments. It may help raise blood pressure and improve outcomes.
This trial tests a medication called angiotensin II (brand name Giapreza) to see if it can raise blood pressure in people who have dangerously low blood pressure after heart surgery. If you or a loved one is in the hospital after heart surgery with low blood pressure that isn't getting better with standard treatments, this study may be an option.
This trial gives a drug called angiotensin II to people in vasoplegic shock (a type of shock where blood vessels stay too relaxed despite other medicines). It tests how the drug affects a kidney-related hormone (renin) and if it can help raise blood pressure.
This trial tests a drug called angiotensin II for people in the emergency room who need a specific dose of norepinephrine (a medicine to raise blood pressure) and are also getting antibiotics. The goal is to see if giving angiotensin II early can help stabilize blood pressure.
This trial tests if starting Angiotensin II early, instead of other blood pressure medications, can help heart surgery patients maintain safe blood pressure. It may be an option if you have low blood pressure after surgery despite receiving fluids.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
Hear when a new Vasodilatory Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.